SARA HANLY: Open Payments
NPI 1639701154 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$710 in 25 payments from 14 companies in 2025. Trend: 2023 $71 · 2024 $709 · 2025 $710
Food & beverage: $710
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $122 |
| Janssen Biotech, Inc. | 4 | $113 |
| Celgene Corporation | 4 | $95 |
| Daiichi Sankyo Inc. | 4 | $85 |
| AstraZeneca Pharmaceuticals LP | 2 | $53 |
| Incyte Corporation | 2 | $36 |
| Geron Corporation | 1 | $33 |
| TerSera Therapeutics LLC | 1 | $32 |
| GENZYME CORPORATION | 1 | $30 |
| Pharmacosmos Therapeutics Inc. | 1 | $28 |
Products named: ALUNBRIG, RYBREVANT, REBLOZYL, Enhertu, OPDIVO, JAKAFI, RYTELO, Zoladex.
Industry payments across FL — which companies pay providers there.
